RX for BB

With the increase in rx and distress in the industry are BB trying to increase their share in the distress market by trying to do rx deals? IK most bb can't do rx due to their balance sheet but if they do not own any of the firm's debt, will they be able to advise for some of the firms or help out their clients in distress in other ways (if so what?)? I know they can do dip + additional financing but I have also seen some BB groups have a rx team that say they do select rx advisory. If so are they able to increase rx deal flow or does it all mainly go to the eb? If anyone has any insights or works in a group like this some info would be appreciated. Thanks.

2 Comments
 

Praesentium repudiandae tenetur aliquam tempora mollitia ad non rerum. Ad rerum enim beatae consequatur quae.

Career Advancement Opportunities

November 2026 Investment Banking

  • Evercore 01 99.5%
  • Moelis & Company 01 99.0%
  • JPMorgan 01 98.4%
  • Guggenheim Partners 02 97.9%
  • Morgan Stanley 06 97.4%

Overall Employee Satisfaction

November 2026 Investment Banking

  • Moelis & Company No 99.5%
  • Morgan Stanley 02 99.0%
  • Evercore 01 98.4%
  • Banco Santander 04 97.9%
  • BMO Capital Markets 13 97.4%

Professional Growth Opportunities

November 2026 Investment Banking

  • Evercore 01 99.5%
  • Moelis & Company 01 99.0%
  • Morgan Stanley 05 98.4%
  • Goldman Sachs 01 97.9%
  • JPMorgan No 97.4%

Total Avg Compensation

November 2026 Investment Banking

  • Vice President (17) $409
  • Associates (58) $261
  • 3rd+ Year Analyst (8) $210
  • 2nd Year Analyst (29) $183
  • Intern/Summer Associate (16) $161
  • 1st Year Analyst (84) $151
  • Intern/Summer Analyst (77) $101
notes
16 IB Interviews Notes

“... there’s no excuse to not take advantage of the resources out there available to you. Best value for your $ are the...”

Leaderboard

success
From 10 rejections to 1 dream investment banking internship

“... I believe it was the single biggest reason why I ended up with an offer...”